Document is current
Any future updates will be listed below
-
Authors
Rosenberger, Daniela C. https://orcid.org/0000-0002-7079-6476
Binzen, Uta https://orcid.org/0000-0002-6706-5488
Treede, Rolf-Detlef https://orcid.org/0000-0001-8065-1708
Greffrath, Wolfgang https://orcid.org/0000-0001-9756-749X
-
Funding
Funding for this research was provided by:
Core Facility Live Cell Imaging Mannheim (DFG INST 91027/9-1 FUGG)
DiaMiCom (IRTG 1874)
SFB1158 (SFB1158 (subproject S01))
- License Information
-
More Information
Article History
Received: 23 October 2019
Accepted: 26 December 2019
First Online: 17 January 2020
Ethics approval and consent to participate
: Human studies and DRG retrieval from rats were approved by the relevant authorities: animal welfare officer of the university clinic of Mannheim (internal notification I-13/03) and the Medical Ethics Commission of the Medical Faculty of Mannheim, University of Heidelberg, Germany (AZ 2008-224N-MA; 2008-230A-MA).
: Human volunteers have consented for data to be used for research and publication purposes.
: Qutenza patches were kindly provided as a gift by Astellas Pharma GmbH (Munich, Germany); these patches were used as a tool to desensitize the skin, Astellas was not involved in planning or performing this study. RDT reports grants from Bayer, DFG, EU, personal fees from Astellas, Bayer, Decision Resources, Grünenthal, GSK, Hydra, Pfizer, all outside the submitted work. This publication contains essential parts of the MD thesis of DR.
